Elite Pharmaceuticals Inc (ELTP)

[carbonfiltered]

Background info on who's representing elite with FDA :

Mr. Eugene M. Pfeifer, also known as Gene, served as a Law Partner at King & Spalding in Washington DC. Mr. Pfeifer was a Law Partner at the Burditt, Bowles & Radzius. Mr. Pfeifer has more than 45 years of regulatory and trade experience. Among his many accomplishments, he was a major participant in the development of the Drug Price Competition and Patent Term Restoration Act of 1984, and provided strategic counseling to companies affected by that statue. In addition, he has provided regulatory advice and representation on a wide variety of FDA, FTC, and DEA regulated activities, including product approval, advertising, promotion, and compliance issues. Prior to working at Burditt, Bowles and Radzius, he served for a year in the General Counsel's office of the Federal Trade Commission, where he represented the FTC in Federal Court to enjoin violations of the Federal Trade Commission Act, and served ten years in the Chief Counsel's Office at the FDA as Associated Chief Counsel for Enforcement, Associate Chief Counsel for Drugs and Deputy Chief Counsel for Regulations and Hearings. Mr. Pfeifer has been a Director at Elite Pharmaceuticals, Inc. since April 07, 2016. During his tenure at the FDA, he was the FDA's lead litigator and Appellate Court advocate, and he briefed the FDA's cases before the Supreme Court. Mr. Pfeifer is a graduate of Brown University and the Georgetown University Law Center.